BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32625976)

  • 21. Safety and efficacy of the feed additive consisting of endo-1,4-beta-xylanase produced by
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Glandorf B; Anguita M; Galobart J; Holczknecht O; Manini P; Pizzo F; Tarrés-Call J; Pettenati E
    EFSA J; 2021 Apr; 19(4):e06539. PubMed ID: 33968246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the feed additive consisting of dimethylglycine sodium salt (Taminizer D) for chickens for fattening for the renewal of its authorisation (Taminco N.V.).
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Brozzi R; Galobart J; Gregoretti L; Innocenti ML; Vettori MV; López-Gálvez G
    EFSA J; 2021 May; 19(5):e06621. PubMed ID: 34093781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Durjava M; Dusemund B; Kouba M; López-Alonso M; Puente SL; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Villa RE; Woutersen R; Cots JGI; Pettenati E; Pagés Plaza D
    EFSA J; 2024 Mar; 22(3):e8650. PubMed ID: 38440252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the application for renewal of authorisation of PHYZYME
    ; Bampidis V; Azimonti G; de Lourdes Bastos M; Christensen H; Dusemund B; Kouba M; Kos Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Aquilina G; Brantom P; Dierick NA; Glandorf B; Herman L; Rychen G; Anguita M
    EFSA J; 2019 May; 17(5):e05701. PubMed ID: 32626323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the application for renewal of authorisation of Levucell
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Kos Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa R; Woutersen R; Chesson A; Cocconcelli PS; Wallace RJ; Rychen G; Brozzi R; Saarela M
    EFSA J; 2018 Jul; 16(7):e05385. PubMed ID: 32626006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Fašmon Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Cocconcelli PS; Glandorf B; Maradona MP; Saarela M; Galobart J; Gregoretti L; Innocenti M; López-Gálvez G; Vettori MV; Brozzi R
    EFSA J; 2021 Mar; 19(3):e06451. PubMed ID: 33732397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Fašmon Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Cocconcelli PS; Glandorf B; Herman L; Prieto Maradona M; Saarela M; Brozzi R; Galobart J; Gregoretti L; López-Gálvez G; Vettori MV; Innocenti ML; Sofianidis K
    EFSA J; 2020 Nov; 18(11):e06280. PubMed ID: 33204311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the application for renewal of authorisation of Levucell SC (
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Kos Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Brozzi R
    EFSA J; 2019 Mar; 17(3):e05639. PubMed ID: 32626262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the application for renewal of authorisation of endo-1,4-β-xylanase produced by
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Cocconcelli PS; Glandorf B; Herman L; Maradona MP; Saarela M; Pettenati E; Anguita M
    EFSA J; 2020 Dec; 18(12):e06331. PubMed ID: 33343730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the feed additive consisting of endo-1,4-β-xylanase produced by
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Durjava MF; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Cocconcelli PS; Glandorf BD; Herman L; Maradona MP; Saarela M; Anguita M; Brozzi R; Galobart J; Gregoretti L; Innocenti ML; López-Gálvez G; Vettori MV; Revez J
    EFSA J; 2021 Feb; 19(2):e06458. PubMed ID: 33664845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of Calsporin
    ; Rychen G; Aquilina G; Azimonti G; Bampidis V; Bastos ML; Bories G; Chesson A; Cocconcelli PS; Flachowsky G; Gropp J; Kolar B; Kouba M; Lopez Puente S; Lopez-Alonso M; Mantovani A; Mayo B; Ramos F; Villa RE; Wallace RJ; Wester P; Brozzi R; Saarela M
    EFSA J; 2017 Apr; 15(4):e04761. PubMed ID: 32625463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Anguita M; Innocenti M; Ortuño J; Pizzo F; Brozzi R
    EFSA J; 2023 Jun; 21(6):e08043. PubMed ID: 37304348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a feed additive consisting of endo-1,4-β-xylanase produced by
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Tosti L; Anguita M; Galobart J; Innocenti M; Pettenati E; Ortuño J
    EFSA J; 2023 Aug; 21(8):e08171. PubMed ID: 37547225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the application for renewal of authorisation of Actisaf
    ; Rychen G; Aquilina G; Azimonti G; Bampidis V; Bastos ML; Bories G; Chesson A; Cocconcelli PS; Flachowsky G; Gropp J; Kolar B; Kouba M; López-Alonso M; López Puente S; Mantovani A; Mayo B; Ramos F; Villa RE; Wallace RJ; Wester P; Aguilera J; Brozzi R; Saarela M
    EFSA J; 2018 Jul; 16(7):e05339. PubMed ID: 32625975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of a feed additive consisting of
    ; Azimonti G; Bampidis V; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Brantom P; Maradona MP; Tosti L; Anguita M; Brozzi R; Galobart J; Pizzo F; Revez J; Ortuño J; Tarrés-Call J; Pettenati E
    EFSA J; 2022 Jun; 20(6):e07342. PubMed ID: 35757152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of a feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Villa RE; Woutersen R; Maradona MP; Alija-Novo N; Anguita M; Innocenti ML; Pettenati E; Revez J; Brozzi R
    EFSA J; 2023 Nov; 21(11):e08355. PubMed ID: 37928943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Durjava M; Dusemund B; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Anguita M; Ortuño J; Revez J; Navarro-Villa A
    EFSA J; 2023 Jun; 21(6):e08053. PubMed ID: 37304354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the application for renewal of the authorisation of PHYZYME
    ; Bampidis V; Azimonti G; de Lourdes Bastos M; Christensen H; Dusemund B; Kouba M; Kos Durjava M; López-Alonso M; López Puente S; Marcon F; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Anguita M; Pettenati E; Mayo B
    EFSA J; 2019 May; 17(5):e05702. PubMed ID: 32626324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the application for renewal of authorisation of Biosprint
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kos Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Anguita M; Galobart J; Holczknecht O; Manini P; Tarrés-Call J; Pettenati E; Pizzo F
    EFSA J; 2020 Nov; 18(11):e06284. PubMed ID: 33204312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the feed additive consisting of alpha-galactosidase produced by
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Anguita M; Brozzi R; Ortuño J; Pettenati E; Tarrés-Call J; García-Cazorla Y
    EFSA J; 2023 Aug; 21(8):e08175. PubMed ID: 37583944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.